Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « Titre (en) » - entrée « lopinavir »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
loop < lopinavir < loss  Facettes :

List of bibliographic references indexed by lopinavir

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000065 (2020) Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France]"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
000493 (2020) Justin T. Denholm [Australie] ; Joshua Davis [Australie] ; David Paterson [Australie] ; Jason Roberts [Australie, France] ; Susan Morpeth [Nouvelle-Zélande] ; Thomas Snelling [Australie] ; Dominica Zentner [Australie] ; Megan Rees [Australie] ; Matthew O'Sullivan [Australie] ; David Price [Australie] ; Asha Bowen [Australie] ; Steven Y C. Tong [Australie]The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial.
000952 (2020) Minh Patrick Lê [France] ; Pierre Jaquet [France] ; Juliette Patrier [France] ; Paul-Henri Wicky [France] ; Quentin Le Hingrat [France] ; Marc Veyrier [France] ; Juliette Kauv [France] ; Romain Sonneville [France] ; Benoit Visseaux [France] ; Cédric Laouénan [France] ; Lila Bouadma [France] ; Diane Descamps [France] ; Etienne De Montmollin [France] ; Gilles Peytavin [France] ; Jean-François Timsit [France]Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.
000B80 (2020) Romain Arrestier [France] ; Thomas Stehle [France] ; Emmanuel Letavernier [France] ; Armand Mekontso-Dessap [France]Lopinavir-ritonavir associated acute kidney injury is not related to crystalluria in critically-ill COVID-19 patients.
000B81 (2020) Christophe Beyls [France] ; Nicolas Martin [France] ; Alexis Hermida [France] ; Osama Abou-Arab [France] ; Yazine Mahjoub [France]Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit: Risk of Bradycardia.
000B82 (2020) Matthieu Gregoire [France] ; Paul Le Turnier [France] ; Benjamin J. Gaborit [France] ; Gwenaelle Veyrac [France] ; Raphaël Lecomte [France] ; David Boutoille [France] ; Emmanuel Canet [France] ; Berthe-Marie Imbert [France] ; Ronan Bellouard [France] ; François Raffi [France]Lopinavir pharmacokinetics in COVID-19 patients.
001089 (2020) Elise Klement-Frutos [France] ; Sonia Burrel [France] ; Gilles Peytavin [France] ; Stéphane Marot [France] ; Minh P. Lê [France] ; Nagisa Godefroy [France] ; Vincent Calvez [France] ; Anne-Geneviève Marcelin [France] ; Eric Caumes [France] ; Valérie Pourcher [France] ; David Boutolleau [France]Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.
001286 (2020) Marie Lecronier [France] ; Alexandra Beurton [France] ; Sonia Burrel [France] ; Luc Haudebourg [France] ; Robin Deleris [France] ; Julien Le Marec [France] ; Sara Virolle [France] ; Safaa Nemlaghi [France] ; Côme Bureau [France] ; Pierre Mora [France] ; Martin De Sarcus [France] ; Olivier Clovet [France] ; Baptiste Duceau [France] ; Paul Henri Grisot [France] ; Marie Hélène Pari [France] ; Jérémy Arzoine [France] ; Ulrich Clarac [France] ; David Boutolleau [France] ; Mathieu Raux [France] ; Julie Delemazure [France] ; Morgane Faure [France] ; Maxens Decavele [France] ; Elise Morawiec [France] ; Julien Mayaux [France] ; Alexandre Demoule [France] ; Martin Dres [France]Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis.
001762 (2020) Yannick Binois ; Hafsah Hachad ; Joe-Elie Salem ; Julien Charpentier ; Bénédicte Lebrun-Vignes [France] ; Frédéric Pène ; Alain Cariou ; Jean-Daniel Chiche ; Jean-Paul Mira ; Lee S. NguyenAcute kidney injury associated with lopinavir/ritonavir combined therapy in patients with Covid-19.
001787 (2020) Benjamin Batteux [France] ; Sandra Bodeau [France] ; Valérie Gras-Champel [France] ; Sophie Liabeuf [France] ; Jean-Philippe Lanoix [France] ; Jean-Luc Schmit [France] ; Claire Andréjak [France] ; Yoann Zerbib [France] ; Guillaume Haye [France] ; Kamel Masmoudi [France] ; Anne-Sophie Lemaire-Hurtel [France] ; Youssef Bennis [France]Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID-19.
001806 (2020) H. Joumaa [France] ; L. Regard [France] ; N. Carlier [France] ; G. Chassagnon [France] ; E. Alabadan [France] ; E. Canouï [France] ; A. L'Honneur [France] ; F. Rozenberg [France] ; P-R Burgel [France] ; N. Roche [France]A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "lopinavir" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "lopinavir" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    lopinavir
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021